Literature DB >> 24635525

Privileged s-triazines: structure and pharmacological applications.

Dhruvin R Shah1, Rahul P Modh, Kishor H Chikhalia.   

Abstract

This review summarizes recent reports on s-triazine and its respective analogs from the medicinal chemistry angle. Due to its high reactivity and binding characteristic towards various enzymes, s-triazine has attracted attention. This is combined with facile synthesis and interesting pharmacology. The triazine class demonstrates wide biological applications - including antimicrobial, antituberculosis, anticancer, antiviral and antimalarial. In this article the library of s-triazine-based molecular designs has been collated with respective bioactivity. Compounds are further compared with other heterocyclic/nontriazine moieties to correlate the efficiency of privileged s-triazine. We hope this article may assist chemists in their drug design and discovery efforts.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24635525     DOI: 10.4155/fmc.13.212

Source DB:  PubMed          Journal:  Future Med Chem        ISSN: 1756-8919            Impact factor:   3.808


  9 in total

1.  Triazine-Based Covalent DNA-Encoded Libraries for Discovery of Covalent Inhibitors of Target Proteins.

Authors:  Linjie Li; Mingbo Su; Weiwei Lu; Hongzhi Song; Jiaxiang Liu; Xin Wen; Yanrui Suo; Jingjing Qi; Xiaomin Luo; Yu-Bo Zhou; Xin-Hua Liao; Jia Li; Xiaojie Lu
Journal:  ACS Med Chem Lett       Date:  2022-08-15       Impact factor: 4.632

2.  Syntheses and Structural Investigations of Penta-Coordinated Co(II) Complexes with Bis-Pyrazolo-S-Triazine Pincer Ligands, and Evaluation of Their Antimicrobial and Antioxidant Activities.

Authors:  Saied M Soliman; Raghdaa A Massoud; Hessa H Al-Rasheed; Ayman El-Faham
Journal:  Molecules       Date:  2021-06-14       Impact factor: 4.411

3.  Design and Synthesis of Aza-/Oxa Heterocycle-Based Conjugates as Novel Anti-Inflammatory Agents Targeting Cyclooxygenase-2.

Authors:  Sukhmeet Kaur; Priya Kumari; Gurjit Singh; Rajbir Bhatti; Palwinder Singh
Journal:  ACS Omega       Date:  2018-05-30

4.  New Approach for the One-Pot Synthesis of 1,3,5-Triazine Derivatives: Application of Cu(I) Supported on a Weakly Acidic Cation-Exchanger Resin in a Comparative Study.

Authors:  Eva Havránková; Jozef Csöllei; Pavel Pazdera
Journal:  Molecules       Date:  2019-10-05       Impact factor: 4.411

Review 5.  s-Triazine: A Privileged Structure for Drug Discovery and Bioconjugation.

Authors:  Anamika Sharma; Rotimi Sheyi; Beatriz G de la Torre; Ayman El-Faham; Fernando Albericio
Journal:  Molecules       Date:  2021-02-06       Impact factor: 4.411

6.  The Antiproliferative and Apoptotic Effect of a Novel Synthesized S-Triazine Dipeptide Series, and Toxicity Screening in Zebrafish Embryos.

Authors:  Azizah M Malebari; Rakia Abd Alhameed; Zainab Almarhoon; Muhammad Farooq; Mohammad A M Wadaan; Anamika Sharma; Beatriz G de la Torre; Fernando Albericio; Ayman El-Faham
Journal:  Molecules       Date:  2021-02-22       Impact factor: 4.411

7.  Acetic Acid Mediated for One-Pot Synthesis of Novel Pyrazolyl s-Triazine Derivatives for the Targeted Therapy of Triple-Negative Breast Tumor Cells (MDA-MB-231) via EGFR/PI3K/AKT/mTOR Signaling Cascades.

Authors:  Ihab Shawish; Assem Barakat; Ali Aldalbahi; Walhan Alshaer; Fadwa Daoud; Dana A Alqudah; Mazhar Al Zoubi; Ma'mon M Hatmal; Mohamed S Nafie; Matti Haukka; Anamika Sharma; Beatriz G de la Torre; Fernando Albericio; Ayman El-Faham
Journal:  Pharmaceutics       Date:  2022-07-27       Impact factor: 6.525

8.  Synthesis and Characterization of New Series of 1,3-5-Triazine Hydrazone Derivatives with Promising Antiproliferative Activity.

Authors:  Hessa H Al H Al Rasheed; Azizah M M Malebari; Kholood A A Dahlous; Ayman El-Faham
Journal:  Molecules       Date:  2020-06-11       Impact factor: 4.411

9.  Antioxidative Activity of 1,3,5-Triazine Analogues Incorporating Aminobenzene Sulfonamide, Aminoalcohol/Phenol, Piperazine, Chalcone, or Stilbene Motifs.

Authors:  Eva Havránková; Nikola Čalkovská; Tereza Padrtová; Jozef Csöllei; Radka Opatřilová; Pavel Pazdera
Journal:  Molecules       Date:  2020-04-14       Impact factor: 4.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.